← All organizations

Highest phase reached
Phase 3
First clinical trial
Sep 30, 2019Last known activity
Nov 30, 2025
Timeline
2010s
- Jan 1, 2016
Guangdong Raynovent Biotech Co., Ltd— Founded
Drugs by trial phase (17 distinct, 33 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 1 (10 own, 0 via acquisition)
Indications
Recent trials (33)
- NCT07229807Lead sponsorPhase 3Nov 30, 2025
- NCT07229820Lead sponsorPhase 3Nov 8, 2025
- NCT07139548Lead sponsorPhase 3Aug 31, 2025
- NCT07139535Lead sponsorPhase 3Aug 31, 2025
- NCT06893016Lead sponsorPhase 3Jun 15, 2025
- NCT06656026Lead sponsorPhase 2Nov 30, 2024
- NCT06613763Lead sponsorPhase 1Sep 11, 2024
- NCT06577415Lead sponsorPhase 1Aug 26, 2024
- NCT06577428Lead sponsorPhase 1Jul 30, 2024
- NCT06254274Lead sponsorPhase 2Feb 26, 2024
- NCT06254261Lead sponsorPhase 2Feb 21, 2024
- NCT06248567Lead sponsorPhase 1Jan 15, 2024
- NCT06164431Lead sponsorPhase 1Nov 23, 2023
- NCT06157450Lead sponsorPhase 1Oct 11, 2023
- NCT06160622Lead sponsorPhase 1Sep 26, 2023
Details
- Founded
- Guangdong, CN Jan 1, 2016
- Last known activity
- Nov 30, 2025